
US FDA Accepts Aptar’s N-Sorb Nitrosamine Mitigation Solution into Emerging Technology Progra
AptarGroup, Inc. (NYSE: ATR), a global leader in dosing, dispensing, and protection technologies for drug and consumer products, announced that its N-Sorb nitrosamine mitigation solution has been accepted into the U.S. Food & Drug Administration’s (FDA) Emerging Technology Program (ETP).…











